Dr Reddy’s to Commemorate 25 Years of NYSE Listing with Closing Bell Ceremony

Dr Reddy’s Laboratories is to ring the Closing Bell at the New York Stock Exchange (NYSE) on May 29, 2026, marking 25 years since the company’s shares were listed on the US exchange, as per a filing dated May 28, 2026. The company said the ceremony will be held at the NYSE headquarters in New York City. 

The pharmaceutical company was listed on the NYSE in April 2001. At the time, it became the first pharmaceutical company from Asia, excluding Japan, to secure a listing on the exchange. 

Senior Leadership to Attend 

Chairman Satish Reddy and Chief Executive Officer Erez Israeli will be among the executives attending the event. Other members of the leadership team, board representatives, and invited guests are also participating in the ceremony. 

The bell-ringing is scheduled for 4:00 pm EDT on May 29, which corresponds to 1:30 am IST on May 30. The event will be broadcast through NYSE platforms. 

Reference to Company's Early Expansion 

In a statement issued ahead of the event, Satish Reddy said the anniversary marks 25 years of the company’s presence on the NYSE.  

He said the listing reflected the company’s focus on governance standards, transparency, and innovation during its international expansion. 

Reddy also referred to the vision of founder Dr K. Anji Reddy, who established the company in 1984. He noted that the company’s entry into the US market was linked to its efforts to expand access to medicines across geographies. 

Operations Across Markets 

Headquartered in Hyderabad, Dr Reddy’s operates across several pharmaceutical segments, including generic medicines, active pharmaceutical ingredients (APIs), biosimilars, branded generics and over-the-counter products.  

The company has business operations in markets such as India, the United States, Europe, China, Brazil and CIS countries. 

Read More: PGHH Share Price in Focus; Board Appoints Srividya Srinivasan as CFO and Executive Director! 

Dr Reddy’s Laboratories Share Price Performance  

As of May 29, 2026, 12:03 pm, Dr Reddy's Laboratories Ltd share price was trading at ₹1,314.60, down 0.34% from the previous closing price. 

Conclusion 

The NYSE Closing Bell ceremony marks a quarter-century since Dr Reddy’s listing on the exchange, recalling a milestone achieved by the company in April 2001. 

For daily market updates and regular stock market news in Hindi, stay tuned to Angel One's share market news in Hindi. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.   
 
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.